Literature DB >> 9894157

Down-regulation of human FEN-1 gene expression during differentiation of promyelocytic leukemia cells.

I S Kim1.   

Abstract

Flap endo/exonuclease-1 (FEN-1) recognizes 5'-flap DNA structures that have been proposed to be important intermediates in DNA replication, repair and recombination, and cleaves the double strand-single strand junction of flap substrates. Using an in vitro model system, recent studies have shown that FEN-1 is a necessary enzyme for the removal of RNA primers in Okazaki fragment maturation during lagging strand DNA synthesis. In this report, the FEN-1 gene expression was examined during cell cycle and differentiation. Although FEN-1 mRNA and protein could be detected at all stages of the cell cycle, their levels were more elevated in exponentially proliferating cells than in G1 or G2/M-synchronized cells. Moreover, a significant increase of FEN-1 protein was observed when temporarily quiescent fibroblasts were induced to proliferate by serum stimulation. In contrast, the FEN-1 mRNA level showed a sharp decrease in HL-60 cells differentiated by dimethyl-sulfoxide, all-trans retinoic acid or 12-O-tetradecanoylphorbol-13-acetate. These results demonstrate that the FEN-1 gene expression is up-regulated during entrance into the mitotic cell cycle and down-regulated in nongrowing cells, as in the case of differentiated promyelocytic leukemia cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9894157     DOI: 10.1038/emm.1998.37

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  5 in total

1.  Overexpression and hypomethylation of flap endonuclease 1 gene in breast and other cancers.

Authors:  Purnima Singh; Ming Yang; Huifang Dai; Dianke Yu; Qin Huang; Wen Tan; Kemp H Kernstine; Dongxin Lin; Binghui Shen
Journal:  Mol Cancer Res       Date:  2008-11       Impact factor: 5.852

Review 2.  Base excision repair of oxidative DNA damage and association with cancer and aging.

Authors:  Scott Maynard; Shepherd H Schurman; Charlotte Harboe; Nadja C de Souza-Pinto; Vilhelm A Bohr
Journal:  Carcinogenesis       Date:  2008-10-31       Impact factor: 4.944

3.  Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer.

Authors:  Tarek M A Abdel-Fatah; Roslin Russell; Nada Albarakati; David J Maloney; Dorjbal Dorjsuren; Oscar M Rueda; Paul Moseley; Vivek Mohan; Hongmao Sun; Rachel Abbotts; Abhik Mukherjee; Devika Agarwal; Jennifer L Illuzzi; Ajit Jadhav; Anton Simeonov; Graham Ball; Stephen Chan; Carlos Caldas; Ian O Ellis; David M Wilson; Srinivasan Madhusudan
Journal:  Mol Oncol       Date:  2014-05-13       Impact factor: 6.603

4.  Kinetics of endogenous mouse FEN1 in base excision repair.

Authors:  Liv Kleppa; Pierre-Olivier Mari; Elisabeth Larsen; Guro Flor Lien; Camille Godon; Arjan F Theil; Gaute J Nesse; Hege Wiksen; Wim Vermeulen; Giuseppina Giglia-Mari; Arne Klungland
Journal:  Nucleic Acids Res       Date:  2012-07-18       Impact factor: 16.971

5.  The prognostic significance of Flap Endonuclease 1 (FEN1) in breast ductal carcinoma in situ.

Authors:  Abdulbaqi Al-Kawaz; Islam M Miligy; Michael S Toss; Omar J Mohammed; Andrew R Green; Srinivasan Madhusudan; Emad A Rakha
Journal:  Breast Cancer Res Treat       Date:  2021-06-12       Impact factor: 4.872

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.